Case reports present the details of real patient cases from medical or clinical practice. Case reports should contribute significantly to the existing knowledge in the respective field. The report is expected to discuss the symptoms, signs, diagnosis, and treatment of a disease. A goal of case report is to make other researchers aware of the possibility that a specific phenomenon / disease might occur. These shall have academic value and shall report rare presentations of a common disease or common presentations of a rare disease or previously unreported observations (e.g. treatment, complication) of a common disease. They can also include unusual cases of educational significance or the unique use of diagnostic tools to reveal a disease. The journal will not consider case reports describing preventive or therapeutic interventions, as these generally require stronger evidence. These will be published free of cost after editorial check and a maximum of three authors including the corresponding author will be given credit for the case report.
A case report shall have a non-structured abstract of no more than 150 words and three to six keywords as per MeSH.
The main manuscript shall not be more than 1500 words, and shall have the following sections; introduction, case presentation, investigations, differential diagnosis, treatment, outcome and follow-up, discussion, learning points.
Introduction section shall justify the importance of the case being reported.
Case presentation section shall have comprehensive account of presenting features including medical, social and family history, your findings.
Investigations section shall outline all the investigations that are crucial to the management decisions and should be discussed. Also include the limitations of investigations, if needed. Any images, videos shall be mentioned in the case report maintaining patient’s confidentiality.
Differential diagnosis sections shall have a description (not just a list) of the differential diagnoses.
Treatment section shall mention all pharmacological and non-pharmacological measures.
Outcome and follow-up section shall detail the outcome of the case and follow-up period if relevant.
Discussion section shall include brief summary of similar published cases or relevant clinical guidelines.
Learning points sections shall highlight the points you want the readers to remember in their own practice.
A declarations section (with the following subheadings: Patients consent for use of data for publication, Authors’ contributions, Conflict of interest, Funding, Acknowledgments) shall be placed after Learning points section and before References.
The manuscript shall be supported by not more than 10 references.
It is mandatory to provide institutional / ethical approval letter for the case report the time of submission. The letter shall mention names of all authors, title of the clinical audit report, name of the approving body, and number and date of approval.